Vaccinex logo
Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds
18 sept. 2024 08h30 HE | Vaccinex, Inc.
ROCHESTER, N.Y., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to...
Athira Pharma Logo RGB_300ppi.jpg
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
17 sept. 2024 09h00 HE | Athira Pharma, Inc.
ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion expected by year end 2024 and commencement of dosing of...
Veera Anantha
VitalCaring’s AI-driven Cognitive Care Pilot Shows Promising Results
12 sept. 2024 07h26 HE | Constant Therapy Health; VitalCaring
VitalCaring’s AI-driven cognitive care pilot shows statistically significant cognitive improvements. Provider to extend initiative across its network.
Athira Pharma Logo RGB_300ppi.jpg
Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease
03 sept. 2024 16h01 HE | Athira Pharma, Inc.
LIFT-AD trial did not meet primary endpoint of GST and key secondary endpoints of cognition (ADAS-Cog11) and function (ADCS-ADL23)  In pre-specified subgroups of patients with moderate Alzheimer’s...
logo.jpg
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
28 août 2024 09h00 HE | AC Immune SA
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions PI-2620 is in Phase 3 development in Alzheimer’s disease by AC Immune’s...
Author Sonya Jury Shares Life Lessons in Her New Book Mom Forgot My Birthday: A Daughter’s Journey Through Alzheimer’s
26 août 2024 07h00 HE | Sonya Jury, Author
Sonya Jury shares her lessons as a caregiver in her book, "Mom Forgot My Birthday: A Daughter’s Journey Through Alzheimer’s."
Ivor HS
Tiziana Life Sciences Appoints New Chief Executive Officer
19 août 2024 07h00 HE | Tiziana Life Sciences Ltd.
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Federal report illum
Federal report illuminates need for disability inclusion in clinical trials
14 août 2024 12h18 HE | National Council on Disability
WASHINGTON, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Today, the National Council on Disability (NCD) released a timely report on exclusionary practices that prevent people with disabilities from...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
01 août 2024 16h05 HE | Athira Pharma, Inc.
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024
31 juil. 2024 08h05 HE | Athira Pharma, Inc.
Fosgonimeton mitigated amyloid-β-induced toxicity, lowered pTau levels and reduced disruption of protein clearance mechanisms that may contribute to pTau pathology Fosgonimeton treatment,...